The University of Chicago Header Logo

Connection

Larry Kociolek to Humans

Back to Details
This is a "connection" page, showing publications Larry Kociolek has written about Humans.
Larry Kociolek
Connection Strength
1.262
Humans
  1. Clostridioides difficile in Children. Infect Dis Clin North Am. 2025 Dec; 39(4):709-725.
    View in: PubMed
    Score: 0.029
  2. Impact of universal masking by pediatric healthcare personnel on non-SARS-CoV-2 healthcare-associated viral respiratory infections: A quasi-experimental study. Am J Infect Control. 2025 06; 53(6):735-738.
    View in: PubMed
    Score: 0.028
  3. Infection Prevention and Control Implications of Special Pathogens in Children. Pediatr Clin North Am. 2024 06; 71(3):431-454.
    View in: PubMed
    Score: 0.026
  4. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023 04; 44(4):527-549.
    View in: PubMed
    Score: 0.024
  5. Association Between Clostridium innocuum and Antibiotic-Associated Diarrhea in Adults and Children: A Cross-sectional Study and Comparative Genomics Analysis. Clin Infect Dis. 2023 02 08; 76(3):e1244-e1251.
    View in: PubMed
    Score: 0.024
  6. Implementation of a Structured Process for Clinically Indicated Testing for Clostridioides difficile Infections in Pediatric Oncology and Stem Cell Transplant. J Pediatr Hematol Oncol Nurs. 2023 May-Jun; 40(3):188-194.
    View in: PubMed
    Score: 0.024
  7. Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):440-447.
    View in: PubMed
    Score: 0.024
  8. Incidence and Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 Infection After Vaccination in Children. J Pediatr. 2022 12; 251:196-201.e4.
    View in: PubMed
    Score: 0.023
  9. Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies. Anaerobe. 2022 Jun; 75:102555.
    View in: PubMed
    Score: 0.023
  10. Translational Aspects of the Immunology of Clostridioides difficile Infection: Implications for Pediatric Populations. J Pediatric Infect Dis Soc. 2021 Nov 17; 10(Supplement_3):S8-S15.
    View in: PubMed
    Score: 0.022
  11. Clostridioides difficile Infection in Children: Research Progress, Pitfalls, and Priorities. J Pediatric Infect Dis Soc. 2021 Nov 17; 10(Supplement_3):S1-S2.
    View in: PubMed
    Score: 0.022
  12. Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children. Curr Opin Infect Dis. 2021 10 01; 34(5):527-532.
    View in: PubMed
    Score: 0.022
  13. Viral whole-genome sequencing to assess impact of universal masking on SARS-CoV-2 transmission among pediatric healthcare workers. Infect Control Hosp Epidemiol. 2022 10; 43(10):1408-1412.
    View in: PubMed
    Score: 0.022
  14. Screening Students and Staff for Asymptomatic Coronavirus Disease 2019 in Chicago Schools. J Pediatr. 2021 Dec; 239:74-80.e1.
    View in: PubMed
    Score: 0.022
  15. Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen. Anaerobe. 2021 Oct; 71:102418.
    View in: PubMed
    Score: 0.022
  16. Viral Loads of SARS-CoV-2 in Young Children-Reply. JAMA Pediatr. 2021 05 01; 175(5):530-531.
    View in: PubMed
    Score: 0.021
  17. Impact of an automated multiple emitter whole-room ultraviolet-C disinfection system on hospital acquired infections: A quasi-experimental study. Am J Infect Control. 2021 09; 49(9):1200-1203.
    View in: PubMed
    Score: 0.021
  18. Coronavirus disease 2019 vaccine hesitancy among children's hospital staff: A single-center survey. Infect Control Hosp Epidemiol. 2021 06; 42(6):775-777.
    View in: PubMed
    Score: 0.021
  19. Moving the Needle on Clostridioides difficile Research in Children: A Major Step Forward but Challenges Remain. Clin Infect Dis. 2020 12 17; 71(10):2589-2591.
    View in: PubMed
    Score: 0.021
  20. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs. J Clin Microbiol. 2020 12 17; 59(1).
    View in: PubMed
    Score: 0.021
  21. Severe Acute Respiratory Syndrome Coronavirus 2 Point Prevalence Among Asymptomatic Hospitalized Children and Subsequent Healthcare Worker Evaluation. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):617-619.
    View in: PubMed
    Score: 0.021
  22. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19). JAMA Pediatr. 2020 09 01; 174(9):902-903.
    View in: PubMed
    Score: 0.020
  23. Fidaxomicin for the treatment of Clostridioides difficile in children. Future Microbiol. 2020 07; 15:967-979.
    View in: PubMed
    Score: 0.020
  24. Stewardship of personal protective equipment (PPE): An important pandemic resource for PPE preservation and education. Infect Control Hosp Epidemiol. 2021 05; 42(5):636-637.
    View in: PubMed
    Score: 0.020
  25. SARS-CoV-2 Infection in Infants Less than 90 Days Old. J Pediatr. 2020 Sep; 224:150-152.
    View in: PubMed
    Score: 0.020
  26. Natural Clostridioides difficile Toxin Immunization in Colonized Infants. Clin Infect Dis. 2020 05 06; 70(10):2095-2102.
    View in: PubMed
    Score: 0.020
  27. Association Between Children's Hospital Visitor Restrictions and Healthcare-Associated Viral Respiratory Infections: A Quasi-Experimental Study. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):240-243.
    View in: PubMed
    Score: 0.020
  28. An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc. 2019 Dec 27; 8(6):580-584.
    View in: PubMed
    Score: 0.020
  29. Clostridioides difficile Whole-Genome Sequencing Reveals Limited Within-Host Genetic Diversity in a Pediatric Cohort. J Clin Microbiol. 2019 09; 57(9).
    View in: PubMed
    Score: 0.019
  30. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Transpl Infect Dis. 2019 Oct; 21(5):e13149.
    View in: PubMed
    Score: 0.019
  31. Response to: Treatment of (Recurrent) Clostridioides difficile Infections in Children and Adults. J Pediatr Gastroenterol Nutr. 2019 08; 69(2):e58-e59.
    View in: PubMed
    Score: 0.019
  32. Lack of false-positive results for Clostridioides difficile toxins A and B using two commercial enzyme immunoassays in pediatric patients. Infect Control Hosp Epidemiol. 2019 07; 40(7):825-826.
    View in: PubMed
    Score: 0.019
  33. Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey. Infect Control Hosp Epidemiol. 2019 03; 40(3):276-280.
    View in: PubMed
    Score: 0.018
  34. Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains. Anaerobe. 2018 Dec; 54:1-7.
    View in: PubMed
    Score: 0.018
  35. Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis. Clin Infect Dis. 2018 07 02; 67(2):229-234.
    View in: PubMed
    Score: 0.018
  36. Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital. J Antimicrob Chemother. 2018 05 01; 73(5):1222-1229.
    View in: PubMed
    Score: 0.017
  37. Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106. Microbes Infect. 2018 04; 20(4):245-253.
    View in: PubMed
    Score: 0.017
  38. Clostridium difficile infection and commonly used pediatric medications. J Pediatr. 2017 11; 190:287-290.
    View in: PubMed
    Score: 0.017
  39. Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):142-148.
    View in: PubMed
    Score: 0.016
  40. Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics. J Clin Microbiol. 2017 05; 55(5):1244-1248.
    View in: PubMed
    Score: 0.016
  41. Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients. Antimicrob Agents Chemother. 2016 08; 60(8):4896-900.
    View in: PubMed
    Score: 0.015
  42. Breakthroughs in the treatment and prevention of Clostridium difficile infection. Nat Rev Gastroenterol Hepatol. 2016 Mar; 13(3):150-60.
    View in: PubMed
    Score: 0.015
  43. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions. Pediatr Infect Dis J. 2016 Feb; 35(2):157-61.
    View in: PubMed
    Score: 0.015
  44. Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027. J Clin Microbiol. 2016 Jan; 54(1):19-24.
    View in: PubMed
    Score: 0.015
  45. Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study. J Pediatr. 2015 Aug; 167(2):384-9.
    View in: PubMed
    Score: 0.014
  46. Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study. Infect Control Hosp Epidemiol. 2015 Apr; 36(4):445-51.
    View in: PubMed
    Score: 0.014
  47. Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection. J Pediatric Infect Dis Soc. 2015 Dec; 4(4):e139-42.
    View in: PubMed
    Score: 0.014
  48. Is pediatric Clostridium difficile infection associated with prior antibiotic exposure? Future Microbiol. 2014; 9(7):825-8.
    View in: PubMed
    Score: 0.013
  49. National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations. Am J Infect Control. 2013 Oct; 41(10):933-5.
    View in: PubMed
    Score: 0.012
  50. In the clinic. Pharyngitis. Ann Intern Med. 2012 Sep 04; 157(5):ITC3-1 - ITC3-16.
    View in: PubMed
    Score: 0.012
  51. Cost of a Measles Outbreak in an Urban Shelter. JAMA Netw Open. 2026 Sep 01; 9(9):e2635328.
    View in: PubMed
    Score: 0.008
  52. A novel integrative and conjugative element in Streptococcus pyogenes carries a cfr-like gene associated with linezolid resistance in other species. mSphere. 2026 Sep 29; 11(9):e0027726.
    View in: PubMed
    Score: 0.008
  53. Identification of Streptococcus pyogenes isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitis. Antimicrob Agents Chemother. 2026 07; 70(7):e0035426.
    View in: PubMed
    Score: 0.008
  54. Efficacy of atropine as a chronotropic agent in heart transplant patients undergoing dobutamine stress echocardiography. Echocardiography. 2006 May; 23(5):383-7.
    View in: PubMed
    Score: 0.008
  55. Pediatric Infectious Diseases Physicians' Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network Survey. J Pediatric Infect Dis Soc. 2026 Jan 17; 15(1).
    View in: PubMed
    Score: 0.007
  56. Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020-2024. Emerg Infect Dis. 2025 Aug; 31(8):1550-1560.
    View in: PubMed
    Score: 0.007
  57. Phenotypic analysis of various Clostridioides difficile ribotypes reveals consistency among core processes. Appl Environ Microbiol. 2025 07 23; 91(7):e0096425.
    View in: PubMed
    Score: 0.007
  58. Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant. Transpl Infect Dis. 2025 Jul-Aug; 27(4):e70030.
    View in: PubMed
    Score: 0.007
  59. Outcomes Associated with Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals. J Pediatric Infect Dis Soc. 2024 Nov 27; 13(11):594-598.
    View in: PubMed
    Score: 0.007
  60. SHEA practice update: infection prevention and control (IPC) in residential facilities for pediatric patients and their families. Infect Control Hosp Epidemiol. 2025 01; 46(1):3-26.
    View in: PubMed
    Score: 0.007
  61. Children's Hospital Resource Utilization During the 2022 Viral Respiratory Surge. Pediatrics. 2024 07 01; 154(1).
    View in: PubMed
    Score: 0.007
  62. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient. Virol J. 2023 10 27; 20(1):246.
    View in: PubMed
    Score: 0.006
  63. Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates. Infect Control Hosp Epidemiol. 2023 10; 44(10):1533-1539.
    View in: PubMed
    Score: 0.006
  64. Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates. Infect Control Hosp Epidemiol. 2023 10; 44(10):1540-1554.
    View in: PubMed
    Score: 0.006
  65. Targeted Vaccine Messaging to Promote COVID-19 Vaccines for Children and Youth. Pediatrics. 2023 06 01; 151(6).
    View in: PubMed
    Score: 0.006
  66. Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):265-272.
    View in: PubMed
    Score: 0.006
  67. Intestinal bile acids provide a surmountable barrier against C. difficile TcdB-induced disease pathogenesis. Proc Natl Acad Sci U S A. 2023 05 09; 120(19):e2301252120.
    View in: PubMed
    Score: 0.006
  68. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. Lancet Infect Dis. 2023 07; 23(7):e259-e265.
    View in: PubMed
    Score: 0.006
  69. Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients. J Pediatr Gastroenterol Nutr. 2023 04 01; 76(4):440-446.
    View in: PubMed
    Score: 0.006
  70. Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2023 09; 44(9):1403-1409.
    View in: PubMed
    Score: 0.006
  71. Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):454-458.
    View in: PubMed
    Score: 0.006
  72. Factors Associated With Severe Illness in Patients Aged <21 Years Hospitalized for COVID-19. Hosp Pediatr. 2022 09 01; 12(9):760-783.
    View in: PubMed
    Score: 0.006
  73. Clostridioides difficile Infection in Hospitalized Pediatric Patients: Comparisons of Epidemiology, Testing, and Treatment from 2013 to 2019. J Pediatr. 2023 01; 252:111-116.e1.
    View in: PubMed
    Score: 0.006
  74. Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative. JAMA Pediatr. 2022 07 01; 176(7):690-698.
    View in: PubMed
    Score: 0.006
  75. Severe Hepatitis in Pediatric Coronavirus Disease 2019. J Pediatr Gastroenterol Nutr. 2022 05 01; 74(5):631-635.
    View in: PubMed
    Score: 0.006
  76. COVID-19-Related Submission Priorities From the Journal of the Pediatric Infectious Diseases Society. J Pediatric Infect Dis Soc. 2022 Jan 27; 11(1):1-2.
    View in: PubMed
    Score: 0.006
  77. Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 12 31; 70(5152):1766-1772.
    View in: PubMed
    Score: 0.006
  78. Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc. 2021 Nov 11; 10(10):937-939.
    View in: PubMed
    Score: 0.006
  79. Conversations With the Editors: The Emergence of Variants Amid Population-Wide SARS-CoV-2 Vaccination Efforts: How Much Should We Worry? Clin Ther. 2021 10; 43(10):1630-1635.
    View in: PubMed
    Score: 0.005
  80. SHEA Pediatric Leadership Council commentary: Supporting well child care during the coronavirus disease 2019 (COVID-19) pandemic with personal protective equipment in the ambulatory setting. Infect Control Hosp Epidemiol. 2021 08; 42(8):985-988.
    View in: PubMed
    Score: 0.005
  81. SHEA Pediatric Leadership Council commentary: Personal protective equipment during care of children with multisystem inflammatory syndrome in children (MIS-C). Infect Control Hosp Epidemiol. 2021 09; 42(9):1108-1110.
    View in: PubMed
    Score: 0.005
  82. SHEA Pediatric Leadership Council commentary: Ambulatory management of neonates born to mothers infected with severe acute respiratory coronavirus virus 2 (SARS-CoV-2). Infect Control Hosp Epidemiol. 2021 09; 42(9):1105-1107.
    View in: PubMed
    Score: 0.005
  83. Prevalence and Characteristics of Non-Beta-Lactam Allergy Labeling at a Children's Hospital. J Pediatric Infect Dis Soc. 2021 05 28; 10(5):702.
    View in: PubMed
    Score: 0.005
  84. Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic. Clin Ther. 2021 06; 43(6):e163-e172.
    View in: PubMed
    Score: 0.005
  85. Surveillance Cultures and Infection in 230 Pacemaker and Defibrillator Generator Changes in Pediatric and Adult Congenital Patients. World J Pediatr Congenit Heart Surg. 2021 05; 12(3):331-336.
    View in: PubMed
    Score: 0.005
  86. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health. 2021 03; 5(3):167-177.
    View in: PubMed
    Score: 0.005
  87. Pediatric research priorities in healthcare-associated infections and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2021 05; 42(5):519-522.
    View in: PubMed
    Score: 0.005
  88. Documentation of Indications: Agreement Between Order Entry and Clinical Notes and Effect on Time to Antibiotic Administration. J Pharm Pract. 2022 Feb; 35(1):13-19.
    View in: PubMed
    Score: 0.005
  89. Benign course of SARS-CoV-2 infection in a series of pediatric oncology patients. Pediatr Blood Cancer. 2020 09; 67(9):e28504.
    View in: PubMed
    Score: 0.005
  90. Ideal and Actual Impact of Rapid Diagnostic Testing and Antibiotic Stewardship on Antibiotic Prescribing and Clinical Outcomes in Children With Positive Blood Cultures. Pediatr Infect Dis J. 2019 02; 38(2):131-137.
    View in: PubMed
    Score: 0.005
  91. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):130-143.
    View in: PubMed
    Score: 0.005
  92. Utilizing the electronic health record to construct antibiograms for previously healthy children with urinary tract infections. Infect Control Hosp Epidemiol. 2018 12; 39(12):1473-1475.
    View in: PubMed
    Score: 0.004
  93. Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
    View in: PubMed
    Score: 0.004
  94. Safety of Palivizumab Stewardship in Conjunction with Infection Prevention and Control Strategies for Healthcare-Associated Respiratory Syncytial Virus Infections. Infect Control Hosp Epidemiol. 2018 04; 39(4):485-487.
    View in: PubMed
    Score: 0.004
  95. Central venous catheter salvage in children with Staphylococcus aureus central line-associated bloodstream infection. Pediatr Surg Int. 2017 Nov; 33(11):1201-1207.
    View in: PubMed
    Score: 0.004
  96. Optimizing empiric therapy for Gram-negative bloodstream infections in children. J Hosp Infect. 2018 Jun; 99(2):145-147.
    View in: PubMed
    Score: 0.004
  97. Clostridium difficile-Diagnostic and Clinical Challenges. Clin Chem. 2016 Feb; 62(2):310-4.
    View in: PubMed
    Score: 0.004
  98. Chicago Ebola Response Network (CERN): A Citywide Cross-hospital Collaborative for Infectious Disease Preparedness. Clin Infect Dis. 2015 Nov 15; 61(10):1554-7.
    View in: PubMed
    Score: 0.004
  99. Infection prevention and control in residential facilities for pediatric patients and their families. Infect Control Hosp Epidemiol. 2013 Oct; 34(10):1003-41.
    View in: PubMed
    Score: 0.003
  100. P450c17 deficiency caused by compound heterozygosity for two novel mutations presenting as hypotension in early infancy. Horm Res Paediatr. 2011; 76(6):434-41.
    View in: PubMed
    Score: 0.003
  101. Serial changes in systolic and diastolic echocardiographic indices as predictors of outcome in patients with decreased left ventricular ejection fraction. Eur J Echocardiogr. 2007 Oct; 8(5):369-74.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.